Retatrutide 20mg/Vial 90 Day Protocol
High-purity peptide for research use
$2800.00
Peptide Class or Classification
Triple hormone receptor agonist (GLP-1/GIP/glucagon); investigational peptide therapeutic; multi-agonist incretin modulator.
Top 5 Benefits and Uses
Induces significant fat loss and appetite suppression
Improves glycemic control through insulin enhancement and glucagon modulation
Promotes increased energy expenditure via glucagon receptor activation
Investigated for NASH, metabolic syndrome, and insulin resistance
Shows potential in treating obesity-related inflammation and liver fibrosis
Retatrutide is an investigational triagonist peptide that simultaneously targets three key metabolic receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. Retatrutide represents a next-generation incretin-based therapy with the aim of surpassing the metabolic effects of previous mono- and dual-agonists like Semaglutide and Tirzepatide. The compound entered clinical trials in the early 2020s for obesity, type 2 diabetes, and non-alcoholic steatohepatitis (NASH), with promising early data indicating unprecedented weight loss and glycemic improvements.
Unlock new possibilities in your research with our Retatrutide 20mg/vial, meticulously produced for laboratory and investigational use. Each clear sterile vial contains 20mg of premium-grade Retatrutide, rigorously manufactured to the highest quality standards to ensure consistent performance and results you can trust in every experiment. Ideal for advanced scientific applications, this reliable reagent helps support innovative breakthroughs in your lab. Conveniently sized for ease of use and storage, and delivered in tamper-evident packaging for added quality assurance.
No Refunds Policy – Peptide Orders
All peptide sales are final. Due to the sensitive nature of research peptides, we cannot accept returns or issue refunds once an order has been placed. This policy ensures product integrity, safety, and compliance. Please review your order carefully before completing your purchase.
– Consulting Service Disclaimer
The services and documents provided by Anura Therapeutics are for consulting and educational purposes only. They are not intended to diagnose, treat, cure, or prevent any disease, and do not replace professional medical advice.
Clients are responsible for ensuring compliance with all applicable federal, state, and local laws regarding the handling, sale, or distribution of peptides or related compounds. Anura Therapeutics makes no guarantees regarding regulatory approval, merchant processing, insurance coverage, or liability protection.
By accepting services, the client agrees that Anura Therapeutics, its consultants, and affiliates assume no liability for misuse, misinterpretation, or subsequent legal/medical outcomes.